as on December 5, 2025 at 2:24 am IST
Day's Low
Day's High
0.78%
Downside
1.85%
Upside
52 Week's Low
52 Week's High
46.70%
Downside
8.75%
Upside
Check Incyte Corporation market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$19.9B
EPS (TTM)
6.8518
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
2.91%
PE Ratio (TTM)
17.31
Industry PE ratio
19.200384615384614
PEG Ratio
0.1327
EBITDA
1.3B
Revenue (TTM)
4.8B
Profit Margin
24.70%
Return On Equity TTM
30.39%
Track how Incyte Corporation P/E has moved over time to understand its valuation trends.
Incyte Corporation in the last 5 years
Lowest (-188.08x)
December 31, 2020
Today (17.31x)
December 4, 2025
Industry (19.20x)
December 4, 2025
Highest (151.83x)
September 30, 2024
Today’s Price to Earnings Ratio: 17.31x
Compare market cap, revenue, PE, and other key metrics of Incyte Corporation with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $19.9B | 22.08% | 17.31 | 24.70% | |
| BUY | $44.1B | 415.15% | -16.34 | -264.83% | |
| BUY | $61.4B | 265.31% | 1408.88 | 1.36% | |
| BUY | $111.1B | 102.84% | 29.93 | 31.35% | |
| BUY | $78.6B | 46.95% | 17.98 | 32.13% |
The Incyte Corporation stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Incyte Corporation investment value today
Current value as on today
₹1,40,755
Returns
₹40,755
(+40.76%)
Returns from Incyte Corporation Stock
₹34,656 (+34.66%)
Dollar Returns*
₹6,099 (+6.1%)
Based on 29 analysts
55.17%
Buy
44.83%
Hold
0.00%
Sell
Based on 29 analysts, 55.17% of analysts recommend a 'BUY' rating for Incyte Corporation. Average target price of $95.57
Get share price movements and forecasts by analysts on Incyte Corporation.
What analysts predicted
-5.14%DOWNSIDE
Target Price
$95.57
Current Price
$100.48
Analyzed by
29 Analysts
Target
$95.57
Incyte Corporation target price $95.57, a slight downside of -5.14% compared to current price of $100.48. According to 29 analysts rating.
Search interest for Incyte Corporation Stock has increased by 59% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:59% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 3 quarters, 1.05B → 1.36B (in $), with an average increase of 12.2% per quarter
Profit Spike
![]()
Netprofit is up for the last 3 quarters, 158.20M → 424.16M (in $), with an average increase of 32.7% per quarter
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 915.1% return, outperforming this stock by 893.0%
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 174.4% return, outperforming this stock by 138.4%
Price Dip
![]()
In the last 7 days, INCY stock has moved down by -3.9%
| Organisation | Incyte Corporation |
| Headquarters | 1801 Augustine Cut-Off, Wilmington, DE, United States, 19803 |
| Industry | Health Technology |
| CEO | Mr. Herve Hoppenot |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Ms. Soni K. Basi Ph.D. | Executive VP & Chief Human Resources Officer |
Mr. Herve Hoppenot | Advisor to CEO & Director |
Dr. Steven H. Stein M.D. | Executive VP & Chief Medical Officer |
Mr. Michael James Morrissey | Executive VP & Head of Global Technical Operations |
Ms. Alexis Smith | Vice President & Head of Investor Relations |
Ms. Pamela M. Murphy | Vice President of Investor Relations & Corporate Communications |
Dr. Pablo J. Cagnoni M.D., Ph.D. | President and Head of Research & Development |
Mr. William Meury | CEO, President & Director |
Mr. Thomas Tray | Principal Financial Officer, VP of Finance & Chief Accounting Officer |
Ms. Sheila A. Denton J.D. | Executive VP, General Counsel & Corporate Secretary |
Incyte Corporation share price today is $100.48 as on at the close of the market. Incyte Corporation share today touched a day high of $102.34 and a low of $99.7.
Incyte Corporation share touched a 52 week high of $109.28 on and a 52 week low of $53.56 on . Incyte Corporation stock price today i.e. is closed at $100.48,which is 8.05% down from its 52 week high and 87.60% up from its 52 week low.
Incyte Corporation market capitalisation is $0.02T as on .
Indian investors can start investing in Incyte Corporation (INCY) shares with as little as ₹89.888 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹898.88 in Incyte Corporation stock (as per the Rupee-Dollar exchange rate as on ).
Based on Incyte Corporation share’s latest price of $100.48 as on December 5, 2025 at 2:24 am IST, you will get 0.0995 shares of Incyte Corporation. Learn more about
fractional shares .
Incyte Corporation stock has given 22.08% share price returns and 21.47% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?